129 related articles for article (PubMed ID: 2315685)
1. Thyrotropin receptor antibodies associated with post-operative relapse of thyrotoxicosis in a pregnancy complicated by neonatal thyrotoxicosis.
Wilson R; Fraser WD; Gray CE; Alroomi LG; Thomson JA
Scott Med J; 1990 Feb; 35(1):21-2. PubMed ID: 2315685
[TBL] [Abstract][Full Text] [Related]
2. Can thyroid stimulating hormone levels by TSH (IRMA) predict relapse of thyrotoxicosis following carbimazole treatment?
Wilson R; Semple CG; Reid AM; Glen AC; McKillop JH; Thomson JA
Postgrad Med J; 1987 Sep; 63(743):755-6. PubMed ID: 3444799
[TBL] [Abstract][Full Text] [Related]
3. [Graves disease in pregnancy a risk for the child. Maternal TSH receptor antibodies can cause fetal and neonatal thyrotoxicosis].
Roos M; Sjöberg O; Axelsson O; Karlsson FA
Lakartidningen; 2008 Jan 16-22; 105(3):120-4. PubMed ID: 18290505
[No Abstract] [Full Text] [Related]
4. Congenital thyrotoxicosis in premature infants.
Smith C; Thomsett M; Choong C; Rodda C; McIntyre HD; Cotterill AM
Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of circulating thyroid-stimulating activities in pregnant women with Graves' disease: differential measurement of activities induced by TSH receptor antibody and hCG].
Kaneda T; Tamaki H; Hidaka Y; Amino N; Mitsuda N; Tanizawa O; Miyai K
Rinsho Byori; 1992 Sep; 40(9):941-7. PubMed ID: 1434029
[TBL] [Abstract][Full Text] [Related]
6. Maternal Thyrotropin Receptor Antibody Concentration and the Risk of Fetal and Neonatal Thyrotoxicosis: A Systematic Review.
van Dijk MM; Smits IH; Fliers E; Bisschop PH
Thyroid; 2018 Feb; 28(2):257-264. PubMed ID: 29325496
[TBL] [Abstract][Full Text] [Related]
7. [Hyperthyroidism in a premature infant due to transplacental passage of maternal thyrotropin receptor antibodies].
Rink T; Wieg C; Schroth HJ; Helisch A; Bertram U
Nuklearmedizin; 1999; 38(5):156-9. PubMed ID: 10488483
[TBL] [Abstract][Full Text] [Related]
8. [Neonatal hyperthyroidism in a premature infant born to a mother with Grave's disease].
Nicaise C; Gire C; Brémond V; Minodier P; Soula F; d'Ercole C; Palix C
Arch Pediatr; 2000 May; 7(5):505-8. PubMed ID: 10855389
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
10. [Transient neonatal hyperthyroidism caused by transplacental transport of pituitary TSH receptor antibodies].
Thibault H; Breton D; Brauner R
Arch Fr Pediatr; 1993; 50(7):581-3. PubMed ID: 8002722
[TBL] [Abstract][Full Text] [Related]
11. The ability of the serum thyrotrophin receptor antibody (TRAb) index and HLA status to predict long-term remission of thyrotoxicosis following medical therapy for Graves' disease.
Wilson R; McKillop JH; Henderson N; Pearson DW; Thomson JA
Clin Endocrinol (Oxf); 1986 Aug; 25(2):151-6. PubMed ID: 3491692
[TBL] [Abstract][Full Text] [Related]
12. Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report.
Ting MK; Hsu BR; Huang YY; Lin JD; Chen TC
Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):492-7. PubMed ID: 10584424
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves' disease patients: a sequential study before, during and after pregnancy.
González-Jiménez A; Fernández-Soto ML; Escobar-Jiménez F; Glinoer D; Navarrete L
Thyroidology; 1993 Apr; 5(1):13-20. PubMed ID: 7508738
[TBL] [Abstract][Full Text] [Related]
14. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
15. Thyrotoxicosis in pregnancy.
Emerson CH
Curr Ther Endocrinol Metab; 1994; 5():275-7. PubMed ID: 7704731
[No Abstract] [Full Text] [Related]
16. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease.
Bjørgaas MR; Farstad H; Christiansen SC; Blaas HG
Horm Res Paediatr; 2013; 79(1):39-43. PubMed ID: 23154300
[TBL] [Abstract][Full Text] [Related]
17. Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment.
Tamaki H; Amino N; Aozasa M; Mori M; Iwatani Y; Tachi J; Nose O; Tanizawa O; Miyai K
Am J Perinatol; 1988 Apr; 5(2):152-8. PubMed ID: 2450549
[TBL] [Abstract][Full Text] [Related]
18. [Neonatal hyperthyroidism caused by TSH receptor antibodies in maternal autoimmune hyperthyroidism].
Resch B; Mache C; Rosegger H; Häusler M
Z Geburtshilfe Neonatol; 1995; 199(6):248-52. PubMed ID: 8581851
[TBL] [Abstract][Full Text] [Related]
19. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H
Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease.
Hidaka Y; Amino N; Iwatani Y; Itoh E; Matsunaga M; Tamaki H
J Clin Endocrinol Metab; 1993 Dec; 77(6):1667-70. PubMed ID: 8263157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
